FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer

The tyrosine kinase receptor, HER2 is a crucial prognostic marker and therapeutic target for breast cancer; however, the downstream targets and biological effectors of HER2 remain unclear. We investigated the relationship between HER2 and the transcription factor FoxM1 in breast cancer. HER2 and Fox...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Francis, Richard E., Myatt, Stephen S., Krol, Janna, Hartman, Johan, Peck, Barrie, McGovern, Ursula B., Wang, Jun, Guest, Stephanie K., Filipovic, Aleksandra, Gojis, Ondrej, Palmieri, Carlo, Peston, David, Shousha, Sami, Yu, Qunyan, Sicinski, Piotr, Coombes, R. Charles, Lam, Eric W.-F.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3065068/
https://ncbi.nlm.nih.gov/pubmed/19513552
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items